# Reinilde Heyrman

> Reinilde Heyrman, MD, is Chief Medical Officer of Medpace's Medical Department, where she brings a career spanning pharmaceutical development, biotech leadership, clinical operations, and contract research. Educated at the University of Antwerp and based in Cincinnati, she has held senior roles at Sankyo and Daiichi Sankyo, Ikaria, Bellerophon Therapeutics, Insmed, and her own consultancy before joining Medpace in 2017. Her public writing and interviews emphasize flexible strategic planning, scientific rigor, candid evaluation of advice, strong execution, and accountability to the sponsor.

- **Role:** Chief Medical Officer, Medical Department at Medpace
- **Organizations:** Medpace, Heyrman Pharma Consulting, Insmed, Bellerophon Therapeutics, Ikaria, Daiichi Sankyo Pharma Development, Sankyo Pharma Development, Pharmacia & Upjohn, University of Antwerp
- **Education:** MD, Medicine, University of Antwerp
- **Known for:** Named a Healthcare Businesswomen's Association Rising Star in 2007., Credited as an author or co-author across a substantial clinical-research publication record; ResearchGate lists 48 publications., Co-authored research on model-supported development of fixed-dose combination therapy and other clinical-development studies.

## Career timeline

- **1998-2001** — Associate Director at Pharmacia & Upjohn.
- **2001-2002** — Director, Clinical Research at Sankyo Pharma Development.
- **2002-2005** — Senior Director, Clinical Research at Sankyo Pharma Development.
- **2005-2012** — Held clinical-development leadership roles at Daiichi Sankyo Pharma Development, becoming Vice President, Clinical Development.
- **2007** — Recognized as a Healthcare Businesswomen's Association Rising Star while at Daiichi Sankyo.
- **2012-2014** — Vice President and Chief Clinical Development Officer at Ikaria.
- **2014-2015** — Vice President, Chief Clinical Development Officer and Secretary at Bellerophon Therapeutics.
- **2015-2016** — Senior Vice President, Clinical Development and Operations at Insmed.
- **2016-2017** — Principal at Heyrman Pharma Consulting.
- **2017** — Joined Medpace as Vice President of the Medical Department.
- **2021-2023** — Senior Vice President of the Medical Department at Medpace.
- **2023-present** — Chief Medical Officer of the Medical Department at Medpace.

## Achievements

- Named a Healthcare Businesswomen's Association Rising Star in 2007.
- Credited as an author or co-author across a substantial clinical-research publication record; ResearchGate lists 48 publications.
- Co-authored research on model-supported development of fixed-dose combination therapy and other clinical-development studies.
- Held chief clinical-development roles at both Ikaria and Bellerophon Therapeutics.
- Advanced through Vice President and Senior Vice President roles after joining Medpace in 2017, becoming Chief Medical Officer in 2023.

## Latest updates

- **2026-08** — Medpace's leadership page lists Heyrman as Chief Medical Officer of the Medical Department.
- **2026-08** — Her public LinkedIn profile continues to identify Cincinnati as her location and shows recent engagement with Medpace clinical-research content.
- **2023-03** — Became Chief Medical Officer at Medpace after serving as Senior Vice President of the Medical Department.

## Links

- Website: https://www.medpace.com/about/leadership/
- LinkedIn: https://www.linkedin.com/in/reinilde-heyrman-9181135

---

Profile page: https://yespress.io/reinilde-heyrman
Published by YesPress — https://yespress.io
Last updated: 2026-08-11